Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer.
Di Modica M, Gargari G, Regondi V, Bonizzi A, Arioli S, Belmonte B, De Cecco L, Fasano E, Bianchi F, Bertolotti A, Tripodo C, Villani L, Corsi F, Guglielmetti S, Balsari A, Triulzi T, Tagliabue E. Di Modica M, et al. Among authors: balsari a. Cancer Res. 2021 Apr 15;81(8):2195-2206. doi: 10.1158/0008-5472.CAN-20-1659. Epub 2021 Jan 22. Cancer Res. 2021. PMID: 33483370 Free article.
Combined targeting of EGFR and HER2 against prostate cancer stem cells.
Rossini A, Giussani M, Ripamonti F, Aiello P, Regondi V, Balsari A, Triulzi T, Tagliabue E. Rossini A, et al. Among authors: balsari a. Cancer Biol Ther. 2020 May 3;21(5):463-475. doi: 10.1080/15384047.2020.1727702. Epub 2020 Feb 23. Cancer Biol Ther. 2020. PMID: 32089070 Free PMC article.
HER2 as a target for breast cancer therapy.
Tagliabue E, Balsari A, Campiglio M, Pupa SM. Tagliabue E, et al. Among authors: balsari a. Expert Opin Biol Ther. 2010 May;10(5):711-24. doi: 10.1517/14712591003689972. Expert Opin Biol Ther. 2010. PMID: 20214497 Review.
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.
Campiglio M, Bufalino R, Sandri M, Ferri E, Aiello RA, De Matteis A, Mottolese M, De Placido S, Querzoli P, Jirillo A, Bottini A, Fantini M, Bonetti A, Pedani F, Mauri M, Molino A, Ferro A, Pupa SM, Sasso M, Ménard S, Balsari A, Tagliabue E. Campiglio M, et al. Among authors: balsari a. Breast Cancer Res Treat. 2011 Jul;128(1):147-54. doi: 10.1007/s10549-011-1484-4. Epub 2011 Apr 11. Breast Cancer Res Treat. 2011. PMID: 21479926 Clinical Trial.
The HER2 World: Better Treatment Selection for Better Outcome.
Tagliabue E, Campiglio M, Pupa SM, Balsari A, Ménard S. Tagliabue E, et al. Among authors: balsari a. J Natl Cancer Inst Monogr. 2011;2011(43):82-5. doi: 10.1093/jncimonographs/lgr041. J Natl Cancer Inst Monogr. 2011. PMID: 22043048
191 results